Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/111680
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Glutathione and mitochondria

AutorRibas, Vicent CSIC ORCID; García-Ruiz, Carmen CSIC ORCID ; Fernández-Checa, José C. CSIC ORCID
Palabras claveGlutathione
Cholasteral
Mitochondrail
Reactive oxygen species
Steatohepatitis
Alzheimier disease
Fecha de publicación1-jul-2014
EditorFrontiers Media
CitaciónFrontiers in Pharmacology 5:151 (2014)
ResumenGlutathione (GSH) is the main non-protein thiol in cells whose functions are dependent on the redox-active thiol of its cysteine moiety that serves as a cofactor for a number of antioxidant and detoxifying enzymes. While synthesized exclusively in the cytosol from its constituent amino acids, GSH is distributed in different compartments, including mitochondria where its concentration in the matrix equals that of the cytosol. This feature and its negative charge at physiological pH imply the existence of specific carriers to import GSH from the cytosol to the mitochondrial matrix, where it plays a key role in defense against respiration-induced reactive oxygen species and in the detoxification of lipid hydroperoxides and electrophiles. Moreover, as mitochondria play a central strategic role in the activation and mode of cell death, mitochondrial GSH has been shown to critically regulate the level of sensitization to secondary hits that induce mitochondrial membrane permeabilization and release of proteins confined in the intermembrane space that once in the cytosol engage the molecular machinery of cell death. In this review, we summarize recent data on the regulation of mitochondrial GSH and its role in cell death and prevalent human diseases, such as cancer, fatty liver disease, and Alzheimer's disease. © 2014 Ribas, Garcia-Ruiz and Fernandez-Checa.
Versión del editorhttp://dx.doi.org/10.3389/fphar.2014.00151
URIhttp://hdl.handle.net/10261/111680
DOI10.3389/fphar.2014.00151
Identificadoresdoi: 10.3389/fphar.2014.00151
issn: 1663-9812
Aparece en las colecciones: (IIBB) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Ribas-Frontiers-Pharmacology-2014-5-151.pdf1,99 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

214
checked on 22-abr-2024

SCOPUSTM   
Citations

396
checked on 15-abr-2024

WEB OF SCIENCETM
Citations

376
checked on 24-feb-2024

Page view(s)

357
checked on 23-abr-2024

Download(s)

449
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.